Published in Circulation on December 18, 2001
Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents. Am Heart J (2014) 1.26
A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr (2008) 0.96
The dollars and sense of drug-eluting stents. CMAJ (2005) 0.81
A value-based analysis of hemodynamic support strategies for high-risk heart failure patients undergoing a percutaneous coronary intervention. Am Health Drug Benefits (2013) 0.79
The disutility of restenosis--the impact of repeat percutaneous coronary intervention on quality of life. Can J Cardiol (2010) 0.75
Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis. Am Heart J (2007) 0.75
Linking primary care performance to outcomes of care. J Fam Pract (1998) 6.83
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1993) 6.52
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol (1995) 4.10
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med (2001) 3.85
Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med (2000) 3.70
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med (2001) 2.83
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol (2001) 2.74
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation (1999) 2.67
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv (2000) 2.42
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation (1997) 2.15
The problem of arteria lusoria in right transradial coronary angiography and angioplasty. Catheter Cardiovasc Interv (2001) 1.92
Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med (2001) 1.87
Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation (1991) 1.83
Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol (1998) 1.79
Antifungal activity of tioconazole (UK-20,349), a new imidazole derivative. Antimicrob Agents Chemother (1979) 1.75
The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol (2001) 1.74
The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding. Protein Sci (1996) 1.65
Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med (1996) 1.63
Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J (2001) 1.61
Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol (2000) 1.60
Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn (1996) 1.54
Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation (2000) 1.54
Organizational and financial characteristics of health plans: are they related to primary care performance? Arch Intern Med (2000) 1.52
Seasonal variation in coronary artery disease mortality in Hawaii: observational study. BMJ (1998) 1.51
Feasibility of routine transradial coronary angiography: a single operator's experience. J Invasive Cardiol (1999) 1.49
Control of shear stress in the epicardial coronary arteries of humans: impairment by atherosclerosis. J Am Coll Cardiol (1989) 1.48
Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. Cathet Cardiovasc Diagn (1997) 1.47
Late results of percutaneous transluminal coronary angioplasty of two or more major native coronary arteries. Am J Cardiol (1994) 1.46
Coronary angiography using 4 or 6 French diagnostic catheters: a prospective, randomized study. J Invasive Cardiol (2001) 1.45
Interventional cardiology in Europe 1994. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1998) 1.44
Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PCTA) Cathet Cardiovasc Diagn (1998) 1.44
Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol (1995) 1.43
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn (1996) 1.43
Amplatzing a 6 Fr Judkins right guiding catheter for increased success in complex right coronary artery anatomy. Catheter Cardiovasc Interv (2001) 1.43
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation (1990) 1.42
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol (1995) 1.40
Coronary angioplasty using 5 French guiding catheters: preliminary experience. Catheter Cardiovasc Interv (2000) 1.40
Percutaneous triple-valve balloon valvuloplasty in a pregnant woman. Cathet Cardiovasc Diagn (1991) 1.39
Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. Cathet Cardiovasc Diagn (1995) 1.39
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation (1996) 1.39
Clinical outcomes following "rescue" administration of abciximab in patients undergoing percutaneous coronary angioplasty. J Invasive Cardiol (2000) 1.38
Successful reversal of cardiogenic shock precipitated by saphenous vein graft distal embolization using aspiration thrombectomy. Cathet Cardiovasc Diagn (1994) 1.38
Cardioversion in patients with atrial fibrillation and left atrial thrombi on initial transesophageal echocardiography: should transesophageal echocardiography be repeated before elective cardioversion? A cost-effectiveness analysis. J Am Soc Echocardiogr (1999) 1.38
Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.36
A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation (1992) 1.32
Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol (1998) 1.30
Radial approach: what about the learning curve? Cathet Cardiovasc Diagn (1997) 1.25
Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation (2002) 1.16
Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol (2001) 1.13
Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group. J Am Coll Cardiol (1996) 1.13
Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol (2001) 1.12
Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2001) 1.11
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol (1997) 1.11
Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : intravascular ultrasound study of 2256 patients. Circulation (2000) 1.10
Stenting of bifurcation lesions: a rational approach. J Interv Cardiol (2001) 1.07
Glidewire treatment of resistant coronary occlusions. Cathet Cardiovasc Diagn (1993) 1.07
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab (2000) 1.06
A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation (1992) 1.06
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation (1987) 1.06
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. J Am Coll Cardiol (1999) 1.05
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol (1998) 1.03
Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography. J Antimicrob Chemother (1983) 1.03
A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol (1997) 1.03
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol (2001) 1.03
Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studies. Arch Surg (1997) 1.02
Application of a new phased-array ultrasound imaging catheter in the assessment of vascular dimensions. In vivo comparison to cineangiography. Circulation (1990) 1.02
Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry). Am J Cardiol (1994) 1.02
Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol (1997) 1.02
Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol (2000) 1.02
Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. Circulation (1996) 1.02
Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation (1999) 1.00
Effects of left bundle branch block on the events of the cardiac cycle. Acta Cardiol (1988) 0.99
Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty Registry. Circulation (1994) 0.98
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol (2001) 0.97
Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology (1999) 0.96
Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation (1990) 0.96
Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Med Care (2001) 0.96
Preparation of alkylamine and 125I-radiolabeled derivatives of hyaluronic acid uniquely modified at the reducing end. Anal Biochem (1984) 0.96
Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators. J Invasive Cardiol (2000) 0.96
Clinically guided closure of femoral arterial pseudoaneurysms complicating cardiac catheterization and coronary angioplasty. Cathet Cardiovasc Diagn (1993) 0.94
Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol (1995) 0.94
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. Circulation (1996) 0.93
Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris. Am J Cardiol (1999) 0.91
Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?: A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system. Neth Heart J (2010) 0.91